Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene V Bijnsdorp

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|April 26, 2011
Analysis of drug interactionsIrene V Bijnsdorp, Elisa Giovannetti, Godefridus J Peters
Oncology Reports|July 4, 2013
Profiling of the calcitonin-calcitonin receptor axis in primary prostate cancer: clinical implications and molecular correlatesArvind Thakkar, Irene V Bijnsdorp, Albert A Geldof, et al.
FEBS Letters|June 15, 2019
Urinary exosomal proteins as (pan-)cancer biomarkers: insights from the proteomeLeyla Ayse Erozenci, Franziska Böttger, Irene V Bijnsdorp, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 4, 2023
A Robust and Clinically Applicable Sample Preparation Protocol for Urinary Extracellular Vesicle Isolation Suitable for Mass Spectrometry-Based ProteomicsLeyla A Erozenci, Irene V Bijnsdorp, Sander R Piersma, et al.
Nucleosides, Nucleotides & Nucleic Acids|December 3, 2011
Lipophilic prodrugs and formulations of conventional (deoxy)nucleoside and fluoropyrimidine analogs in cancerGodefridus J Peters, Auke D Adema, Irene V Bijnsdorp, et al.
Cancers|July 10, 2019
Prostate Cancer Development Is Not Affected by Statin Use in Patients with Elevated PSA LevelsDennie Meijer, R Jeroen A van Moorselaar, André N Vis, et al.
Molecular Diagnosis & Therapy|March 17, 2017
The Non-Coding Transcriptome of Prostate Cancer: Implications for Clinical PracticeIrene V Bijnsdorp, Martin E van Royen, Gerald W Verhaegh, et al.
International Journal of Cancer|October 10, 2009
Differential activation of cell death and autophagy results in an increased cytotoxic potential for trifluorothymidine compared to 5-fluorouracil in colon cancer cellsIrene V Bijnsdorp, Godefridus J Peters, Olaf H Temmink, et al.
Scientific Reports|August 3, 2021
Longitudinal stability of urinary extracellular vesicle protein patterns within and between individualsLeyla A Erozenci, Sander R Piersma, Thang V Pham, et al.
Cancer Science|November 6, 2009
Molecular mechanism underlying the synergistic interaction between trifluorothymidine and the epidermal growth factor receptor inhibitor erlotinib in human colorectal cancer cell linesIrene V Bijnsdorp, Frank A E Kruyt, Masakazu Fukushima, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|April 26, 2011
Analysis of drug interactionsIrene V Bijnsdorp, Elisa Giovannetti, Godefridus J Peters
Oncology Reports|July 4, 2013
Profiling of the calcitonin-calcitonin receptor axis in primary prostate cancer: clinical implications and molecular correlatesArvind Thakkar, Irene V Bijnsdorp, Albert A Geldof, et al.
FEBS Letters|June 15, 2019
Urinary exosomal proteins as (pan-)cancer biomarkers: insights from the proteomeLeyla Ayse Erozenci, Franziska Böttger, Irene V Bijnsdorp, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 4, 2023
A Robust and Clinically Applicable Sample Preparation Protocol for Urinary Extracellular Vesicle Isolation Suitable for Mass Spectrometry-Based ProteomicsLeyla A Erozenci, Irene V Bijnsdorp, Sander R Piersma, et al.
Nucleosides, Nucleotides & Nucleic Acids|December 3, 2011
Lipophilic prodrugs and formulations of conventional (deoxy)nucleoside and fluoropyrimidine analogs in cancerGodefridus J Peters, Auke D Adema, Irene V Bijnsdorp, et al.
Cancers|July 10, 2019
Prostate Cancer Development Is Not Affected by Statin Use in Patients with Elevated PSA LevelsDennie Meijer, R Jeroen A van Moorselaar, André N Vis, et al.
Molecular Diagnosis & Therapy|March 17, 2017
The Non-Coding Transcriptome of Prostate Cancer: Implications for Clinical PracticeIrene V Bijnsdorp, Martin E van Royen, Gerald W Verhaegh, et al.
International Journal of Cancer|October 10, 2009
Differential activation of cell death and autophagy results in an increased cytotoxic potential for trifluorothymidine compared to 5-fluorouracil in colon cancer cellsIrene V Bijnsdorp, Godefridus J Peters, Olaf H Temmink, et al.
Scientific Reports|August 3, 2021
Longitudinal stability of urinary extracellular vesicle protein patterns within and between individualsLeyla A Erozenci, Sander R Piersma, Thang V Pham, et al.
Cancer Science|November 6, 2009
Molecular mechanism underlying the synergistic interaction between trifluorothymidine and the epidermal growth factor receptor inhibitor erlotinib in human colorectal cancer cell linesIrene V Bijnsdorp, Frank A E Kruyt, Masakazu Fukushima, et al.
Pageof 4